Streetbeat News

Stock Prices

GDEV

GDEV Inc. issued a statement clarifying that sanctions against former director and current minority shareholder Ivan Tavrin have no direct impact on the company. Tavrin, who holds 5.9% of GDEV's shares through Kismet Sponsor Limited, was added to the U.S. SDN List but does not control or influence the company. GDEV, which resumed trading on Nasdaq in March 2023 after a suspension, emphasizes its commitment to corporate governance and adherence to Nasdaq and SEC standards.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:08 pm

BIRK

EZGO

GCT

GDHG

GOTU

HCDI

KXIN

MICS

QSG

SPGC

XPOF

In Wednesday's pre-market session, several consumer discretionary stocks showed significant movement. EZGO Technologies, QuantaSing Group, LL Flooring Holdings, Xponential Fitness, Gaotu Techedu, and Singing Machine Co were gainers, with EZGO leading at a 13.6% increase. On the losing side, Harbor Custom Dev, Golden Heaven Group Hldgs, GigaCloud Tech, Birkenstock Holding, Sacks Parente Golf, and Kaixin Auto Hldgs saw declines, with Harbor Custom Dev dropping 17.2%.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:07 pm

ACON

APVO

CCCC

IKT

JAGX

KTTA

LFMD

MOTS

NMRD

RLAY

RSLS

STTK

In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Shattuck Labs (STTK) saw a substantial increase of 92.9%, while Reshape Lifesciences (RSLS) rose by 51.19%. Other gainers included Inhibikase Therapeutics (IKT), C4 Therapeutics (CCCC), LifeMD (LFMD), and Nemaura Medical (NMRD). Conversely, Motus GI Holdings (MOTS), Pasithea Therapeutics (KTTA), Relay Therapeutics (RLAY), Aptevo Therapeutics (APVO), Jaguar Health (JAGX), and Aclarion (ACON) all saw their stock prices fall.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:07 pm

NMRD

Nemaura Medical, Inc. has been granted a request for continued listing on the Nasdaq under an exception, according to an 8K filing. The exception allows the company to remain listed until April 1, 2024, providing it time to comply with Nasdaq's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:07 pm

ABM

MYNA

RXO

SFWL

In Wednesday's pre-market session, several industrial stocks showed significant movement. Mynaric, American Rebel Holdings, Professional Diversity, Advent Technologies, ABM Industries, and Marti Technologies experienced gains, with ABM Industries releasing Q4 earnings. Conversely, Shengfeng Development, WANG & LEE Group, JE Cleantech Holdings, ShiftPixy, Navios Maritime Holdings, and RXO saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:07 pm

BLND

BTCM

FICO

LPTH

MRDB

MTC

PRSO

QMCO

SCKT

SGN

SMX

SPEC

In Wednesday's pre-market session, several IT stocks showed significant movement. MariaDB (MRDB) saw a 28.6% increase, while Fair Isaac (FICO) rose by 17.23%. Blend Labs (BLND) was up 9.71%, SMX (Security Matters) increased by 9.0%, Quantum (QMCO) by 8.97%, and MMTEC (MTC) by 7.7%. On the downside, Peraso (PRSO) dropped by 10.1%, Socket Mobile (SCKT) by 6.96%, Spectaire Holdings (SPEC) by 6.36%, LightPath Technologies (LPTH) by 5.8%, Signing Day Sports (SGN) by 5.19%, and BIT Mining (BTCM) by 4.66%.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:07 pm

DSGR

Distribution Solutions Group (DSGR) has announced a new share repurchase program authorizing the buyback of up to $25 million of its shares. This move reflects the company's confidence in its financial strength and commitment to delivering shareholder value. The repurchase program allows DSGR to buy back shares opportunistically, potentially supporting the stock price and earnings per share.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:03 pm

DNLI

Over the past 3 months, 4 Wall Street analysts have provided ratings for Denali Therapeutics (NASDAQ:DNLI), with 1 bullish and 3 somewhat bullish ratings. The average 12-month price target is $31.5, with a high of $35.00 and a low of $28.00, representing a significant decrease from the previous target of $85.00. This suggests a potential downside of 62.94% from the earlier price target.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:00 pm

MFA

MFA Financial (NYSE:MFA) has received 4 analyst ratings in the last quarter, with 3 being somewhat bullish and 1 indifferent. The average price target is $12.25, representing an upside from the current price of $11.13. This target has decreased by 9.26% from the previous target of $13.50. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:00 pm

BONKUSD

DOGEUSD

PEPEUSD

Crypto analyst Kaleo warns that Pepe (CRYPTO: PEPE) is unlikely to reach all-time highs soon, advising against entering a long position until bullish momentum is observed. Kaleo's stance contrasts with analyst Michael Van de Poppe's bullish sentiment from last week, who suggested buying dips and projected a 30% surge for PEPE.

Portfolio Pulse from Mehab Qureshi

December 13, 2023 | 1:00 pm